Compounds > 3,4-dihydro-5-methyl-1(2h)-isoquinolinone
Page last updated: 2024-09-04

3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 1-oxo-1,2,3,4-tetrahydroisoquinoline

3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with 1-oxo-1,2,3,4-tetrahydroisoquinoline in 1 studies

Compound Research Comparison

Studies
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Trials
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Recent Studies (post-2010)
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)		Studies
(1-oxo-1,2,3,4-tetrahydroisoquinoline)		Trials
(1-oxo-1,2,3,4-tetrahydroisoquinoline)		Recent Studies (post-2010) (1-oxo-1,2,3,4-tetrahydroisoquinoline)
1602805

Protein Interaction Comparison

ProteinTaxonomy3,4-dihydro-5-methyl-1(2h)-isoquinolinone (IC50)1-oxo-1,2,3,4-tetrahydroisoquinoline (IC50)
Protein mono-ADP-ribosyltransferase PARP11Homo sapiens (human)7.9716

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MS; Kirby, IT; Morgan, RK; Rodriguez, K; Vermehren-Schmaedick, A1

Other Studies

1 other study(ies) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and 1-oxo-1,2,3,4-tetrahydroisoquinoline

ArticleYear
Rational Design of Cell-Active Inhibitors of PARP10.
    ACS medicinal chemistry letters, 2019, Jan-10, Volume: 10, Issue:1

    Topics:

2019